Jenburkt Pharmaceuticals informs about annual disclosure
Pursuant to SEBI Circular SEBI/HO/DDHS/CIR/2021/613 dated 10th August, 2021 (updated on 13th April, 2022 by SEBI), Jenburkt Pharmaceuticals has confirmed that for the financial year ended on 31st March, 2026, the company is ‘not a large corporate’ as per the applicability criteria mentioned in Clause 2.1 of Chapter XII therein.
The above information is a part of company’s filings submitted to BSE.
